Hutchison China Meditech Ltd $ 19.12 -0.63 (-3.19%)
Volume:
233,555
Avg Vol (1m):
168,137
Market Cap $:
2.55 Bil
Enterprise Value $:
2.35 Bil
P/E (TTM):
12.16
P/B:
7.38
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Graham Number | ||
|
Price: $19.12 | ||
Manual of Stocks™ Web
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 32.76 | ||
| Equity-to-Asset | 0.7 | ||
| Debt-to-Equity | 0.02 | ||
| Debt-to-EBITDA | -0.07 | ||
| Piotroski F-Score | 3 | ||
| Altman Z-Score | 12.88 | ||
| Beneish M-Score | -2.93 | ||
| WACC vs ROIC | |||
Profitability | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -51.82 | ||
| Net Margin % | -40.86 | ||
| ROE % | -22.86 | ||
| ROA % | -16.63 | ||
| ROC (Joel Greenblatt) % | -557.09 | ||
| 3-Year Revenue Growth Rate | 5.4 | ||
| 3-Year EBITDA Growth Rate | -121.6 | ||
| 3-Year EPS without NRI Growth Rate | -27.8 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 12.16 | ||
| PE Ratio without NRI | 12.16 | ||
| PB Ratio | 7.38 | ||
| PS Ratio | 11.92 | ||
| EV-to-EBIT | -22.73 | ||
| EV-to-EBITDA | -23.71 | ||
| EV-to-Revenue | 11.03 | ||
| Current Ratio | 2.8 | ||
| Quick Ratio | 2.67 | ||
| Days Inventory | 28.96 | ||
| Days Sales Outstanding | 72.84 | ||
| Days Payable | 63.3 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 7.38 | ||
| Price-to-Graham-Number | 2 | ||
| Earnings Yield (Greenblatt) % | -4.4 |